Recently, new diagnostic tools for tuberculosis detection and resistance testing have
become available. The World Health Organization endorses new tuberculosis diagnostics …

Background There is an urgent demand for rapid and accurate drug-susceptibility testing for
the detection of multidrug-resistant tuberculosis. The GenoType MTBDR plus assay is a …

Introduction Currently only limited data exist regarding the availability and clinical use of
molecular and immunological tests for tuberculosis (TB) in the European setting. Methods …

OBJECTIVE: To update a previously reported meta-analysis of evidence regarding the
diagnostic accuracy and performance characteristics of commercial and non-commercial …

Background Every year, at least one million children become ill with tuberculosis and
around 200,000 children die. Xpert MTB/RIF and Xpert Ultra are World Health Organization …

Background Xpert MTB/RIF (Xpert MTB/RIF) and Xpert MTB/RIF Ultra (Xpert Ultra), the
newest version, are the only World Health Organization (WHO)‐recommended rapid tests …

Background Mycobacterium tuberculosis is a leading cause of death worldwide. In multi-
drug resistant tuberculosis (MDR-TB) infectiousness is frequently prolonged, jeopardizing …

Background Newer molecular diagnostics have brought paradigm shift in early diagnosis of
tuberculosis [TB]. WHO recommended use of GeneXpert MTB/RIF [Xpert] for Extra …

SETTINGS: National Tuberculosis (TB) Reference Laboratory and Department of Medical
Microbiology, College of Health Sciences, Makerere University, Kampala, Uganda …

Less than 30% of multidrug-resistant tuberculosis (MDR-TB) patients are currently
diagnosed, due to laboratory constraints. Molecular diagnostics enable rapid and simplified …